TABLE 4.
Anti-malarial drugs used during the study period.
| Anti-malarial drugs | Health facility | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| CCLK | CASOP | |||||
| n | % | 95% CI | n | % | 95% CI | |
| SP | 490 | 78.3 | 74.9–81.3 | 429 | 66.7 | 63.0–70.3 |
| Chloroquine | 15 | 2.4 | 1.5–3.9 | 34 | 3.9 | 3.8–7.3 |
| Quinine | 86 | 13.7 | 11.3–16.7 | 122 | 16.4 | 16.1–22.2 |
| ACT | 35 | 5.6 | 4.0–7.7 | 58 | 7.3 | 7.0–11.5 |
| Total | 626 | - | - | 643 | - | - |
Source: Authors’ original data
Quinine was administered per os, intravenous and intramuscular.
SP and chloroquine were administered per os.
CCLK, Centre Chrétien du Lac Kivu [Lake Kivu Christian Centre]; CASOP, Caisse de Solidarité Ouvrière et Paysanne [Fund of Solidarity Workers and Peasants].
n, given as means of number; SP, sulfadoxine-pyrimethamine; ACT, artemisinin combination therapy; CI, confidence interval.